Over the years, pharmacovigilance (PV) processes have relied on PV professionals manually sifting through large volumes of data to identify, assess, and report Adverse Event (AE) information. However, ...
As biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new way of working. Markus Gershater looks at how automation and artificial ...
Explore how workflow automation has evolved from simple Bash scripts to advanced AI-driven systems, boosting productivity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback